Laparoscopic Roux-en-Y Gastric Bypass vs. Laparoscopic Sleeve Gastrectomy for Morbid Obesity and Diabetes Mellitus: A Meta-Analysis of Sixteen Recent Studies

2012 ◽  
Author(s):  
Ping Li ◽  
Ping Fu ◽  
Jie Chen ◽  
Liu-Hua Wang ◽  
Dao-Rong Wang
Keyword(s):  
Diabetes Mellitus ◽  
Morbid Obesity ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Meta Analysis ◽  
Obesity And Diabetes

Laparoscopic Sleeve Gastrectomy Versus Laparoscopicmini-Gastric Bypass in Management of Morbid Obesity and its Comorbidities

2020 ◽  
Vol 11 (2) ◽  
pp. 2572
Author(s):  
Tantawi Abdel Naeem Mohamed ◽  
Salah Abdel- Razik ◽  
Ayman Mohamed Hassanien ◽  
Tohamy A. Tohamy ◽  
Ashraf Abdel Azeem ◽  
...  
Keyword(s):  
Morbid Obesity ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy

scholarly journals Efficacy of laparoscopic sleeve gastrectomy for patient with morbid obesity and type 1 diabetes mellitus: a case report

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Hidetaka Ichikawa ◽  
Hirofumi Imoto ◽  
Naoki Tanaka ◽  
Hiroaki Musha ◽  
Shojiro Sawada ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Body Weight ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Hba1c Level ◽  
Insulin Dose ◽  
Body Weight Loss

Abstract Background Bariatric surgery is effective for the treatment of patients with morbid obesity and type 2 diabetes mellitus (T2DM), for body weight loss and glycemic control. However, in Japan, there has been no previous report of the effectiveness bariatric surgery in a case of morbid obesity associated with acute onset type 1 diabetes mellitus (T1DM), in which pancreatic β-cells were destroyed and endogenous insulin was depleted. Case presentation A 36-year-old woman with morbid obesity and T1DM, diagnosed when she was 6 years, was admitted for bariatric surgery. At her first consultation, she had a body weight of 106.7 kg and a body mass index of 42.2 kg/m2. Her HbA1c level was 9.0%, with a required daily insulin dose of 75 units. She underwent laparoscopic sleeve gastrectomy. At 1 year after surgery, her body weight had decreased to 81.0 kg and her body mass index to 32.2 kg/m2. In addition, her daily required dose of insulin had decreased to 24 units, with an improvement in her HbA1c level to 7.7%. Conclusions Although further evidence needs to be accumulated, including long-term outcomes, laparoscopic sleeve gastrectomy may provide an effective treatment for patients with morbid obesity and T1DM for body weight loss, improvement in HbA1c level, and insulin dose reduction.

Sign in / Sign up

Export Citation Format

Share Document